AI-Powered Scoliosis Auto-Analysis System Multicenter Development and Validations
Launched by THE UNIVERSITY OF HONG KONG · Nov 23, 2021
Trial Information
Current as of May 30, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new system that uses artificial intelligence (AI) to help doctors diagnose and assess spinal deformities, like scoliosis, which is a condition where the spine curves abnormally. The goal is to make it easier and more accurate for healthcare providers to evaluate these conditions, ultimately helping patients receive better care.
To participate in the trial, you should be an adult with specific spinal deformities such as idiopathic scoliosis or other related conditions. If you are currently recovering from surgery or choose not to have imaging tests, you would not be eligible. During the trial, participants can expect to undergo imaging tests that will be analyzed using the AI system. The trial is currently recruiting participants, and anyone interested should talk to their doctor to learn more about joining.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Idiopathic scoliosis, adult deformity (spondylolisthesis, idiopathic kyphosis, kyphoscoliosis, lordoscoliosis)
- Exclusion Criteria:
- • Refusal for imaging, postoperative patients
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Jason Pui Yin Cheung, MD, MS
Principal Investigator
Queen Mary Hospital, Duchess of Kent Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials